| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
MapLight Therapeutics, Inc.
13G
MPLT · 56565P103
|
7.1% |
2/17/2026
Event 12/31/2025
|
||||
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.1% | |||||
| Forbion Growth III Management B.V. | 7.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.